Visionary pharmacovigilance experts across the world are eager to develop a new global network, to share benefit and risk based intelligence of medicinal products. With the fast spread of globalisation, cross-borders & trade-blocs, medical practitioners and drug manufacturers are force to adopting holistic strategies to battle the increasing pressure from their stake holders. The humble aim of GLC’s 3rd Annual Pharmacovigilance Forum, is to provide a platform for these practitioners in the hope of finding the answers to some of the pressing issues they face nowadays.
Be the first to uncover the first experiences of complete transition from DDPS to PSMF. Listen to industry experts discussing ready-made and tested solutions to transparency issues in ADR. Discover the correct directions, to adhere to upcoming regulatory deadlines, discussed by its creators, if not by its supporters. Witness the highlight of the event, a participative workshop providing practical insights to overcome inefficiencies and redundancies in PV processes. Meet and greet 20+ industry specialists from global conglomerates such as, Novartis, Pfizer, Abbott, Astellas, Takeda and other experts from the European Medicines Agency, The Royal College of Physicians, and the Drug Safety Research Unit surrounded by a selected senior audience from across Europe.
Coupled with a diversified set of thought leaders and a five star environment, this one of a kind symposium, will link drug manufacturers with the medical practitioners, academia’s, PV related associations and governmental representatives from across Europe under one roof.Without a doubt, an exclusive gathering within the PV event space, you cannot afford not to capitalise upon.
Doris Irene Stenver
Member of the Pharmacovigilance Risk Assessment Committee
European Medicines Agency
Director, CPD (Continuing Professional
Development) Faculty of Pharmaceutical
The Royal College of Physicians
Corporate Vice president
Novo Nordisk A/S
Global Head of Pharmacovigilance, EU QPPV
Bert Van Leeuwen
Deputy Qualified Person for Pharmacovigilance (QPPV)
Astellas Pharma Europe
Senior Specialist Medical Safety & Epidemiology
Former Head of Pharmacovigilance
Austrian Agency for Food and Drug Safety(AGES)
Director Pharmacovigilance, QPPV Bavarian
Professor Saad Shakir
Drug Safety Research Unit
Assoc.Prof. of Basic & Clinical Pharmacology
Faculty of Medicine & Pharmacy
Senior Director Risk Management Strategy
Takeda Pharmaceuticals Europe
Peter De Veene
Clinical Safety and Pharmacovigilance
Head of Brussels Office
German Pharmaceutical Industry Association (BPI)
Head of Safety and QPPV
Head Global Drug Safety
Associate Director Global Drug Safety
Benefit-Risk Management Grünenthal
Oxford University/ Harvard University
Pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.
Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com.
PharmaVOICE magazine provides readers with insightful and thought-provoking commentary about the challenges and trends impacting the life-sciences industry in a multiple-perspective format through articles covering a range of issues from molecule through market. PharmaVOICE’s more than 41,000 BPA-qualified subscribers are also kept abreast of the latest trends and information through additional media resources, including WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.
Medical News Today is the largest independent medical and health news site on the web - with over 10,000,000 monthly unique users it is ranked number one for medical news on all major search engines. Medical News Today is used by pharmaceutical, biotech and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted campaigns to HCPs, patients and caregivers. To find out how Medical News Today can help you to reach the right audience contact firstname.lastname@example.org or visit www.medicalnewstoday.com.
Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide.
Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world.
Pharmalicensing, and its sister service Medical Device Licensing (www.medicaldevicelicensingcom) are actively utilized by over 200,000 industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.
Pharmalicensing is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world.
Pharmalicensing, and its sister service Medical Device Licensing (www.medicaldevicelicensing.com) are actively utilized by over 200,000 industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.
"I wish to thank you for inviting me to your Conference which was very interesting and excellently organized."
MSc Programme in Human Resource Management - Athens University of Economics and Business – Greece
"Thank you very much for the excellent experience"
HR Specialist - Millenium BCP – Portugal
"Thank you for what was overall a very good conference: interesting, right speakers, right audience, very good facilitation and proper organization."
HR Director – LibanPost – Lebanon
"The best HR Conference I have ever attended. Congrats and keep up the good job."
Head of HR - Banca Comerciala Carpatica – Romania
"Thanks for a good conference. Many interesting presentations!"
Managing Director – PharmaEvidence
"It was very good to meet you in Frankfurt, and congratulations on organizing such a successful event."
Clinical Director - All Wales Therapeutics and Toxicology Centre - United Kingdom
"It was an excellent one under GLC’s organization; I am honored for being a part of it. I really appreciated of your organization during the Forum from which I benefited a lot, thank you very much for everything indeed, you are wonderful."
Chief Auditor – Central Bank of Turkey –Turkey
"Excellent results. I really enjoyed the conference myself. Think it was well organized and good participation from the audience."
Chief Auditor for Functions and Capital Resolution Group - Royal Bank of Scotland, Internal Audit
"The organization was fantastic"
Director Internal Audit - Bank of Slovenia – Slovenia
"It was a pleasure to attend and speak at the 3rd IA Conference! The environment was outstanding and the presentations were very interesting"
Director of Internal Audit (Head of Group) – Portuguese Mutual Guarantee System (SPGM)
"Thanks a lot for arranging such a good Forum. Thank to GLC for their friendly support"
Head of Internal Audit & Compliance - Eco Trade and Development Bank – Turkey
|GLC - Global Leading Conferences
Hungary H-1134 Budapest, Váci út 19. (Panorama Office Building)
glc(at)glceurope.com +36 1 848 05 32